Market Cap | ₹7,614Cr |
ROE | 13.69% |
P/E Ratio(TTM) | 28.57 |
EPS(TTM) | 29.40 |
P/B Ratio | 3.83 |
Dividend Yield | 0.60% |
Industry P/E | 34.34 |
Book Value | 219.55 |
Debt to Equity | 0.21 |
Face Value | 5 |
Parent Organisation | Aarti Pharmalabs |
NSE Symbol | AARTIPHARM |
FUND NAME | AUM(%) |
---|---|
HDFC Multi Cap Fund Direct Growth | 0.21% |
HDFC Large and Mid Cap Fund Direct Growth | 0.02% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.61 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.39 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.44 | ||
Wockhardt | NA (0.00%) | -188.59 |